Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

2 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 1000

X. budapestensis compound characterization

ABSTRACT: Characterization of active compounds from x. budapestensis

INSTRUMENT(S): 4800 Plus MALDI TOF/TOF, LTQ Orbitrap Elite

ORGANISM(S): Xenorhabdus Budapestensis

SUBMITTER: Greg Barrett-Wilt Susan Paskewitz

PROVIDER: MSV000083089 | MassIVE | Thu Nov 01 14:05:00 GMT 2018

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	MSV000083089	Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS - X. budapestensis compound characterization

Project description:Characterization of active compounds from x. budapestensis

2018-11-01 | MSV000083089 | GNPS

In depth characterization of the activity of a novel synthetic macrocyclic antifungal compound

Project description:The systemic infections by peptogenous fungi member of the genera Candida and Aspergillus represent a serious threat for public health. During previous research we have successfully identified a family of compounds active against different Candida spp. including strains resistant to antifungal drugs currently on the market. We have further refined our knowledge on this field by identifying a possible molecular target that could justify the activity of these compounds. The research of the mode of action of the compounds object of this manuscript was supported also by fluorescent microscopy of labeled derivatives. Transcriptional data indicates that one of the macrocyclic antifungal induces a drug response involving ATP binding cassette transporters. Moreover the data show that the macrocyclic antifungal decrease expression of cell wall biosynthesis genes. Moreover, the quality of the compounds and their potential was tested in vivo revealing a promising profile in particular against fungal infection caused by resistant strains

2015-04-01 | GSE65396 | GEO

In depth characterization of the activity of a novel synthetic macrocyclic antifungal compound

2015-04-01 | E-GEOD-65396 | biostudies-arrayexpress

High-throughput sequencing of OS cells treated with activated compound B5.

Project description:The high-throughput sequencing technology was performed after the treatment of human osteosarcoma cells U2OS and MG63 with the active compound B5 designed and synthesized by ourselves, to explore the expression of genes related to cell adhesion, migration and invasion of human osteosarcoma cells U2OS and MG63 after the treatment of the active compound Changes to explore the effect of active compounds on the motility of osteosarcoma cells.

2020-08-25 | GSE156729 | GEO

High-throughout sequencing of triple negative breast cancer cells treated actived compound D16

Project description:The high-throughput sequencing technology was performed after the treatment of human triple negative breast cancer cells MDA-MB-231 with the active compound D16 designed and synthesized by ourselves, to explore the expression of genes related to cell proliferation, adhesion, migration and invasion of human triple negative breast cancer cells MDA-MB-231 after the treatment of the active compound Changes to explore the effect of active compounds on the proliferation and motility of triple breast breast cancer cells and to find an interesting target gene, CKAP2.

2021-08-17 | GSE182063 | GEO

Characterization of novel natural compound derivatives with cancer-selective cytotoxicity (RNA-seq dataset 2)

Project description:Colorectal cancer is one of the most frequent and lethal cancer in the world. Current therapeutic approaches are still not fully successful, yet cause numerous and severe side effects for the patient. We screened chemically synthesized derivatives from two natural compounds (a-Mangostin and Paeonol) as potential novel chemicals that increase cancer cell selectivity over non-transformed human cells. We found two of them that efficiently induced cell cycle arrest and apoptosis in human cancer cells and organoids derived from tumor tissue without affecting the viability of human non-cancer cells and intestinal organoids derived from healthy tissue. Our findings increase the knowledge about cancer-specific compounds and propose two natural compound derivatives as potential novel chemotherapeutics.

2022-03-04 | GSE154753 | GEO

Characterization of novel natural compound derivatives with cancer-selective cytotoxicity (RNA-seq dataset 1)

2022-03-04 | GSE154752 | GEO

Characterization of novel natural compound derivatives with cancer-selective cytotoxicity (RNA-seq dataset 3)

2022-03-04 | GSE154754 | GEO

Characterization of novel natural compound derivatives with cancer-selective cytotoxicity

Project description:Characterization of novel natural compound derivatives with cancer-selective cytotoxicity

| PRJNA647378 | ENA

Transcriptomic analysis in the developing zebrafish embryo after compound exposure

Project description:Four developmental toxic compounds were tested in concentration-response design, caffeine, carbamazepine, retinoic acid and valproic acid, and two non-embryotoxic compounds, D-mannitol and saccharin, were included.

2014-01-01 | E-MTAB-1476 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data